Cross Country Healthcare to be acquired by Knox Lane for $13.25/share in $437M all-cash deal

CROSS COUNTRY HEALTHCARE INC

Deal valued at ~$437M, with stockholders receiving $13.25 per share in cash.
31% premium to May 6 closing price and 45% premium to 90-day VWAP.
Expected to close Q3 2026, subject to stockholder approval and HSR clearance.
Company cancels Q1 2026 earnings call (May 7) and 2026 Annual Meeting (May 11).
Equity financing from Knox Lane secured; termination fee of ~$14.2M applies.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

CROSS COUNTRY HEALTHCARE INC entered into Merger Agreement with KL Criss Cross Intermediate, LLC and KL Criss Cross Merger Sub, Inc. valued at $13.25 in cash (effective 2026-05-06).

Action: entry
Agreement: merger
Counterparty: KL Criss Cross Intermediate, LLC and KL Criss Cross Merger Sub, Inc.
Value: $13.25 in cash
Effective: 2026-05-06

Exact text from the filing

On May 6, 2026, Cross Country Healthcare, Inc., a Delaware corporation (the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”), by and among the Company, KL Criss Cross Intermediate, LLC, a Delaware limited liability company (“ Parent ”), and KL Criss Cross Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“ Merger Sub ”), pursuant to which Merger Sub will merge with and into the Company (the “ Merger ”), with the Company surviving as a wholly owned subsidiary of Parent

View on SEC.gov

Browse all material agreements →

CROSS COUNTRY HEALTHCARE INC filing history →

Source: SEC EDGAR

accession 0000950103-26-006921

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.